News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

XDx, Inc. Cancels IPO



9/8/2008 8:15:54 AM

XDx Inc., a South San Francisco-based molecular diagnostics company that develops tests for the monitoring of transplant rejection and autoimmune diseases, has withdrawn its registration for an $86.25 million IPO. No reason was given. The company had planned to trade on the Nasdaq, with JPMorgan and Morgan Stanley serving as co-lead underwriters.



comments powered by Disqus
XDx, Inc.
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES